Praxis Precision Medicines (PRAX) Other Non-Current Assets (2019 - 2024)
Praxis Precision Medicines' (PRAX) quarterly Other Non-Current Assets came in at $416000.0 in Q4 2024, little changed year-on-year from $416000.0 in Q1 2024, and little changed quarter-over-quarter from $416000.0 in Q3 2024.
Praxis Precision Medicines (PRAX) Other Non-Current Assets (2019 - 2024) Analysis & Trends
Praxis Precision Medicines' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $416000.0 for Q4 2024.
- On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $416000.0 in Q4 2024; TTM through Dec 2024 was $416000.0, a 0.0% change from a year earlier, with the FY2024 full-year figure at $416000.0, changed 0.0% from the prior year.
- Other Non-Current Assets held at $416000.0 in Q4 2024 per PRAX's latest filing, from $416000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.1 million in Q3 2020 and bottomed at $9000.0 in Q1 2021.
- The 5-year median for Other Non-Current Assets is $416000.0 (2021), against an average of $470333.3.
- Across the five-year window, Other Non-Current Assets plunged 97.58% in 2020 and jumped 4522.22% in 2022, its largest moves.
- Year by year, Other Non-Current Assets stood at $15000.0 in 2020, then surged by 3046.67% to $472000.0 in 2021, then slipped by 11.86% to $416000.0 in 2022, then changed by 0.0% to $416000.0 in 2023, then changed by 0.0% to $416000.0 in 2024.
- Per Business Quant, the three latest PRAX Other Non-Current Assets figures stand at $416000.0 (Q4 2024), $416000.0 (Q3 2024), and $416000.0 (Q2 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Praxis Precision Medicines | 8.98 Bn | 8.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 416,000.00 |
| Sep 30, 2024 | 416,000.00 |
| Jun 30, 2024 | 416,000.00 |
| Mar 31, 2024 | 416,000.00 |
| Dec 31, 2023 | 416,000.00 |
| Sep 30, 2023 | 416,000.00 |
| Jun 30, 2023 | 416,000.00 |
| Mar 31, 2023 | 416,000.00 |
| Dec 31, 2022 | 416,000.00 |
| Sep 30, 2022 | 416,000.00 |
| Jun 30, 2022 | 416,000.00 |
| Mar 31, 2022 | 416,000.00 |
| Dec 31, 2021 | 472,000.00 |
| Sep 30, 2021 | 416,000.00 |
| Jun 30, 2021 | 496,000.00 |
| Mar 31, 2021 | 9,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Sep 30, 2020 | 2.07 Mn |
| Dec 31, 2019 | 620,000.00 |
| Sep 30, 2019 | 600,000.00 |